Biotech Stocks See Volatility as Amgen Falls 10%

Biotech stocks have been making headlines lately, but one company has fallen 10% on news it didn't even run. Amgen, a leading biotechnology firm, saw its stock plummet after a clinical trial result was reported, despite the fact that the company had no involvement in the study.

Amgen is just one of five biotech stocks to watch today, according to MarketBeat's stock screener tool. The other companies on the list are Moderna, Gilead Sciences, AbbVie, and Regeneron Pharmaceuticals.

Biotech stocks can offer significant growth potential but often come with higher risks due to clinical-trial results, regulatory decisions, research costs, and uncertain commercialization timelines.